4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Apollomics, Inc. (APLM) operates in the Biotechnology industry and is headquartered in Foster City, United States with about 14 employees. Its market capitalization is roughly $40 million. In the fiscal year ended 2025-12-31, APLM reported $8M in revenue and ($11M) in net income.
Apollomics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of oncology therapies to harness the immune system and target specific molecular pathways to inhibit cancer.
Interactive charts & full statements → Open the APLM valuation workbench →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Revenue | $8M | $0M | $0M | $0M | — |
| Operating Income (EBIT) | ($9M) | ($42M) | ($54M) | ($44M) | — |
| Net Income | ($11M) | ($54M) | ($173M) | ($241M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Cash flow | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Dividends Paid | $0M | $0M | $0M | $0M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | $7M | $13M | $55M | $76M | — |
| Total Liabilities | $10M | $8M | $14M | $525M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive APLM viewer.
About TickerBase · Data methodology & sources